MedTrace Logo

Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification

NCT06674772 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 440

Last updated 2024-11-13

No results posted yet for this study

Summary

Patients will be asked to visit the study center 2 times, the first time for clinical assessment and a second time for sample collection. Healthy controls will only be asked to visit the study center for sample collection. A sample of blood and saliva will be collected in order to measure CGRP levels and DNA and hormone testing.

Conditions

  • Headache (Migraine)
  • Migraine
  • Migraine Headache
  • Migraine with Aura
  • Migraine Without Aura
  • Episodic Migraine
  • Chronic Migraine Headache
  • Chronic Migraine, Headache
  • Episodic Migraine Headache

Interventions

DIAGNOSTIC_TEST

Saliva test

Sampling of CGRP in saliva and DNA blood test and sex hormones blood test.

Sponsors & Collaborators

  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Eligibility

Min Age
6 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-29
Primary Completion
2025-04-30
Completion
2025-05-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06674772 on ClinicalTrials.gov